These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury. Dorer CL; Manktelow AE; Allanson J; Sahakian BJ; Pickard JD; Bateman A; Menon DK; Stamatakis EA Brain Inj; 2018; 32(8):1040-1049. PubMed ID: 29738277 [TBL] [Abstract][Full Text] [Related]
4. Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging. Jenkins PO; De Simoni S; Bourke NJ; Fleminger J; Scott G; Towey DJ; Svensson W; Khan S; Patel MC; Greenwood R; Friedland D; Hampshire A; Cole JH; Sharp DJ Brain; 2019 Aug; 142(8):2367-2379. PubMed ID: 31199462 [TBL] [Abstract][Full Text] [Related]
5. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis. Coghill DR; Seth S; Pedroso S; Usala T; Currie J; Gagliano A Biol Psychiatry; 2014 Oct; 76(8):603-15. PubMed ID: 24231201 [TBL] [Abstract][Full Text] [Related]
6. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. Willmott C; Ponsford J J Neurol Neurosurg Psychiatry; 2009 May; 80(5):552-7. PubMed ID: 19060022 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study. Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245 [TBL] [Abstract][Full Text] [Related]
9. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial. Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169 [TBL] [Abstract][Full Text] [Related]
10. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies. Jin C; Schachar R CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of stimulants for psychiatric symptoms in individuals with traumatic brain injury. Maksimowski MB; Tampi RR Ann Clin Psychiatry; 2016 Aug; 28(3):156-66. PubMed ID: 27490831 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with methylphenidate for fatigue after traumatic brain injury. Johansson B; Wentzel AP; Andréll P; Rönnbäck L; Mannheimer C Acta Neurol Scand; 2017 Jan; 135(1):100-107. PubMed ID: 26991608 [TBL] [Abstract][Full Text] [Related]
13. Use of methylphenidate in traumatic brain injury. Siddall OM Ann Pharmacother; 2005; 39(7-8):1309-13. PubMed ID: 15914519 [TBL] [Abstract][Full Text] [Related]
14. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits. Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. Stuhec M; Munda B; Svab V; Locatelli I J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457 [TBL] [Abstract][Full Text] [Related]